CHRISTINE ZERR: Open Payments
NPI 1417482282 · LITTLETON, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$27,650 in 240 payments from 21 companies in 2025. Trend: 2023 $9,602 · 2024 $24,899 · 2025 $27,650
Speaker / faculty: $19,750Food & beverage: $4,738Consulting: $1,789Travel & lodging: $1,368Education: $5
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 24 | $9,953 |
| ABBVIE INC. | 51 | $9,850 |
| E.R. Squibb & Sons, L.L.C. | 15 | $5,052 |
| Arcutis Biotherapeutics, Inc. | 18 | $454 |
| Novartis Pharmaceuticals Corporation | 16 | $313 |
| UCB, Inc. | 16 | $260 |
| Galderma Laboratories, L.P. | 23 | $244 |
| Janssen Biotech, Inc. | 21 | $238 |
| Organon LLC | 16 | $225 |
| LEO Pharma Inc. | 3 | $202 |
Products named: DUPIXENT, RINVOQ, Sotyktu, SKYRIZI, Zoryve, TREMFYA, Bimzelx, NEMLUVIO.
Industry payments across CO — which companies pay providers there.
